Search Results 1461-1470 of 28611 for oral

  1. Fentanyl (buccal mucosa route, oromucosal route, sublingual route) - Side effects & dosage - Mayo Clinic

    It is used for breakthrough cancer pain, which are flares of pain that “break through” after a routine pain medicine has been used. Fentanyl belongs to the ...

  2. Codeine, phenylephrine, and promethazine (oral route) - Side effects & dosage - Mayo Clinic

    For non-prescription products, read the label or package ingredients carefully. Pediatric. Use of Promethazine VC with codeine oral liquid in children and ...

  3. Niacin and lovastatin (oral route) - Side effects & dosage - Mayo Clinic

    For oral dosage form (extended-release tablets):. For high cholesterol: Adults—At first, 500 milligrams (mg) of niacin and 20 mg of lovastatin (combined in ...

  4. A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients - Mayo Clinic

    Clinical Trials · A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients · More about research at Mayo ...

  5. A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Patients with Multiple Myeloma Following Autologous Stem Cell Transplant - Mayo Clinic

    A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Patients with Multiple Myeloma Following Autologous Stem Cell Transplant. Print details.

  6. The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS) - Mayo Clinic

    The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) ...

  7. Ombitasvir, paritaprevir, ritonavir and dasabuvir (oral route) - Side effects & dosage - Mayo Clinic

    For oral dosage form (tablets):. For chronic hepatitis C virus infection, with or without ribavirin: Adults—2 pink tablets once a day (taken in the morning) ...

  8. Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin ...

  9. Monday's Housecall - Mayo Clinic News Network

    Did you know that problems in your mouth can affect the rest of your body? Discover the link between oral health and overall health. Male Menopause: Myth or ...

  10. Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies - Mayo Clinic

    The purpose of this study is to demonstrate the effectiveness of neflamapimod, compared to placebo, as a treatment for DLB, as assessed by the Clinical Dementia ...